Virtual Medicinal Product (VMP) - Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension | Start Date 01-05-2012 | End Date |
| Abbreviated Name | Abbreviated Name Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) susp | Start Date 01-05-2012 | |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- Other
Codes
- ATC Code
- A12CC
- BNF Codes
-
- BNF code 09050103
| Code | Start Date | End Date |
|---|---|---|
| 20479111000001104 | 01-05-2012 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Magnesium glycerophosphate | Based on Base Substance | Magnesium | 24.25 mg | 1 ml |
Name
Magnesium glycerophosphate
Basis of strength description
Based on Base Substance
BOSS
Magnesium
Strength and UOM (Nmr)
24.25
Strength and UOM (Dmr)
1
Parent Products
-
VTMMagnesium glycerophosphate
-
VMP(Current) Magnesium glycerophosphate (magnesiu...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml | ||
| 150 ml |